Risk Management & Pharmacovigilance

Real-world evidence UBC
UBC - August 06, 2015
Real-world evidence in the pharmaceutical industry has increasingly influenced stakeholder decision-making. In the past, such data was collected once a drug had been approved. The industry has since shifted to a proactive approach,...
Patient awareness and use of medication guides
Amy Walton, Medical Writer - July 30, 2015
Patient understanding of the risks associated with their medications is critical for safe and effective product use. As the number and complexity of medicinal products on the market increases, communication and education between...
UBC - July 29, 2015
Large, diverse U.S. and European healthcare data sources are increasingly popular, enabling an evidence-based approach to research, development, drug safety, and commercial strategy. However, healthcare data sources are inconsistent...
Pharmacovigilance questions - UBC
UBC - June 24, 2015
Pharmacovigilance measures play a critical role in every phase of a product’s lifecycle, beginning when the first human is given a new investigational drug. However, understanding pharmacovigilance requirements can be daunting, even...
UBC - June 08, 2015
DIA’s slogan, “It’s a Meeting of the Minds” perfectly sums up this banner event for the pharmaceutical and biotech industry. Next week, influential leaders and innovators in life sciences will gather in Washington, D.C., to discuss...

Pages